RARG plays an important role in the proliferation, metastasis, and chemoresistance of cholangiocarcinoma through the simultaneous activation of the Akt/NF-kappaB and Wnt/beta-catenin pathways33. Here, AKT1 is linked to cholangiocarcinoma.